HEMP AND CBD




Hemp & Cannabinoids

The December 2018 Farm Bill marked a new era for federally legal hemp and hemp-derived products, including CBD. However, navigating this rapidly evolving landscape requires careful attention to complex regulations. Notably, the U.S. Drug Enforcement Agency (DEA) proposed an interim final rule on August 21, 2020, stating that any material with more than 0.3% THC on a dry-weight basis remains classified as a Schedule I substance—a critical area of concern for the hemp industry.

As the regulatory environment continues to change, start-ups, existing business owners, and investors involved in cannabis cultivation, manufacturing, transportation, dispensaries, and regulatory compliance face significant challenges. The Law Office of Kimberly R. Simms is dedicated to helping these key players navigate these complexities and plan effectively for success. In such a dynamic sector, failing to stay ahead of regulatory changes can lead to missed opportunities and setbacks.

Business Formation and Strategy

Corporate Governance

Commercial Transactions I Contract drafting and review I Negotiation of contracts I Mergers and Acquisitions

Licensing and Permits

Real Estate and Land Use

Due Diligence and Risk Evaluation

Partnership Dissolution & Business Wind-Up Services

Outside General Counsel

Legal Opinion Letters

Regulatory Compliance

Kimberly R. Simms. All Rights Reserved. | (760) 420-1846 | kimberly@simmslaw.com